News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Vinayak Venkataraman: Appreciated the chance to speak at the 20th Annual Young Adult Cancer Conference
Photo taken from Vinayak Venkataraman/X
May 2, 2024, 16:48

Vinayak Venkataraman: Appreciated the chance to speak at the 20th Annual Young Adult Cancer Conference

Vinayak Venkataraman, Medical Oncologist in the Sarcoma Center at Dana-Farber Cancer Institute, shared on X:

“Appreciated the chance to speak with Adolescents and Young Adults (AYAs) facing cancer at the 20th Annual Young Adult Cancer Conference, hosted by Dana-Farber Young Adult Program on the work we are doing at Dana-Farber Cancer Institute to leverage new ideas and technologies to improve care, research, and outcomes in rare cancers, like sarcomas.”

Vinayak Venkataraman

Source: Vinayak Venkataraman/X

20th Annual Young Adult Cancer Conference Adolescents and Young Adults (AYAs) cancer Dana-Farber Cancer Institute Dana-Farber Young Adult Program OncoDaily Oncology Vinayak Venkataraman
Special Coverage
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Blog
Nov 13, 2024, 08:46
Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer
Blog
Nov 13, 2024, 08:39
Eva Blondeaux on safety of pregnancy in BRCA carriers